Search Results 2071-2080 of 21668 for platelets

1. Neurosurgery - Clinical trials

   ... platelets ≥ 100,000 /microliter, performed within 7 days prior to the collection. Cerebral Spinal Fluid Evaluation in Individuals Who Have Idiopathic ...

2. Cardiovascular Medicine - Clinical trials

   ... Platelet) agents. In addition to exploring ED treatment patterns and success of both ischemic and bleeding risk stratification prior to definition of the ...

3. Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer - Mayo Clinic

   Platelet Count ≥ 75,000/mm^3;; Creatinine ≤ 1.5 x upper limit of normal ULN;; Total Bilirubin ≤ 1.5 x upper limit of normal (ULN);; AST/SGOT ≤ 2.5 x upper ...

4. A Study in Treating Patients With Kidney Cancer Undergoing Nephrectomy Comparing PERioperative Nivolumab vs. Observation - Mayo Clinic

   Platelet count >= 100,000/mm^3, within 4 weeks of randomization. Hemoglobin >= 9.0 g/dL, within 4 weeks of randomization. Serum creatinine =< 1.5 x upper ...

5. MC200404, Safety and Immunogenicity of PolyPEPI1018 Vaccine in the Treatment of Late-stage Metastatic Colorectal Cancer - Mayo Clinic

   Platelet count ≥ 100,000/mm^3;; Hemoglobin ≥ 9 g/dL;; Total bilirubin ≤ 1.5 x ULN;; Alanine aminotransferase (ALT) and aspartate transaminase (AST) ≤3 x ...

6. Trial of Eflornithine Plus Sulindac in Patients with Familial Adenomatous Polyposis (FAP) - Mayo Clinic

   Platelet count at least 100,000/mm3; Hemoglobin at least 10.0 g/dL; No history of clinical coagulopathy. Hepatic Status (within 30 days prior to randomization):.

7. Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients with Early-Stage Breast Cancer that was Removed by Surgery - Mayo Clinic

   Platelet count ≥ 75,000/mm³; Hemoglobin ≥ 8.0 g/dL (transfusion or other intervention to achieve Hgb ≥ 8.0 g/dL is acceptable); Negative urine or serum ...

8. A Study to Evaluate Myeloma-Developing Regimens Using Genomics (MyDRUG) - Mayo Clinic

   PLT ≥ 75,000/ul (Platelet transfusions to help patients meet eligibility criteria are not allowed within 3 days prior to study drug dosing for any dosing day); ...

9. Phase IIB/III of TG4010 Immunotherapy in Patients with Stage IV Non-Small Cell Lung Cancer - Mayo Clinic

   Platelets count ≥ 100x10E9/L; Serum alkaline phosphatase ≤ 3x ULN (upper limit of normal)in the absence of liver or bone metastases or ≤5 ULN(in patients ...

10. A Study to Find the Recommended Dose for Further Research for VX-970 and Whole Brain Radiation Therapy to Treat Patients with Brain Metastases from Non-Small Cell Lung Cancer - Mayo Clinic

    Platelets >= 100,000/mcL; If no known liver metastases: total bilirubin < 1.5 x institutional upper limit of normal (ULN); if known liver metastases, then ...